Amy L. Burroughs - Insider Trading & Ownership

Location
Two Carlson Parkway, Suite 260, Minneapolis, MN
Summary
The estimated net worth of Amy L. Burroughs is at least $387K dollars as of June 25, 2025. Amy L. Burroughs is the Director of DiaMedica Therapeutics Inc. and owns shares of DiaMedica Therapeutics Inc. (DMAC) stock worth about $205K. Amy L. Burroughs is the Chief Executive Officer, Director of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $182K.
Signature
/s/ David Strauss, as Attorney-in-Fact for Amy L. Burroughs
All Insider Reports
All Insider Reports

Ownership of Amy L. Burroughs

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DMAC DiaMedica Therapeutics Inc. Director $205K Jan 3, 2023
TERN Terns Pharmaceuticals, Inc. Chief Executive Officer, Director $182K +$203K Jun 25, 2025
TNYA Tenaya Therapeutics, Inc. Director May 29, 2025

Insider Transactions Reported by Amy L. Burroughs:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.